Preferences for colloid use in Scandinavian intensive care units

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 6, 2008, Pages 750-758

  Perner, A ^a,b   Aneman A ^a,b   Guttormsen, A B ^a,b   Karason S ^a,b   Tenhunen, J ^a,b  

^a Rigshospitalet ^*

^b Rigshospitalet   (Denmark)

Author keywords

Colloids; Fluid therapy; Intensive care; Plasma volume expanders

Indexed keywords

HETASTARCH;

ACUTE KIDNEY FAILURE; ARTICLE; BLEEDING; CLINICAL PROTOCOL; COLLOID; FLUID RESUSCITATION; HYPOVOLEMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERNET; KIDNEY FUNCTION; MORTALITY; PRIORITY JOURNAL; QUESTIONNAIRE; SCANDINAVIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNIVERSITY HOSPITAL;

EID: 45149119684     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01690.x     Document Type: Article

References (19)

1. American Thoracic Society Consensus Statement. Evidence-based colloid use in the critically ill. Am J Respir Crit Care Med 2004 170 : 1247 59.
2. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998 317 : 235 40.
3. Finfer S anders.perner@rh.regionh.dk, Bellomo R, Boyce N et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004 350 : 2247 56.
4. Myburgh J, Cooper DJ, Finfer S et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007 357 : 874 84.
5. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001 357 : 911 6.
6. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 358 : 125 39.
7. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005 49 : 373 8.
8. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005 49 : 1163 71.
9. Oldner A, Rossi P, Karason S et al. A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units. Acta Anaesthesiol Scand 2003 47 : 693 701.
10. Haljamae H. Swedish practice routines for fluid therapy are considerably changing. Läkartidningen 2005 102 : 2659 65.
11. Sakr Y, Payen D, Reinhart K et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007 98 : 216 24.
12. Schortgen F, Deye N, Brochard L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004 30 : 2222 9.
13. Grände PO, Asgeirsson B, Nordstrom CH. Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiol Scand 2002 46 : 929 41.
14. Palumbo D, Servillo G, D'Amato L et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006 72 : 655 64.
15. Reinhart K, Bloos F, Engel C. Hydroxyethyl starch and Ringer's lactate for fluid resuscitation in patients with severe sepsis - results from the VISEP study. Intensive Care Med 2006 32 : S213.
16. Boldt J, Muller M, Mentges D et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998 24 : 28 36.
17. Zander R, Boldt J, Engelmann L et al. The design of the VISEP trial. Critical appraisal. Anaesthesist 2007 56 : 71 7.
18. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001 358 : 581 3.
19. Brown JM, McCormick BA, Vella K et al. Use of albumin in intensive care units in the United Kingdom. Crit Care Resusc 2001 3 : 19 21.